Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Understanding Heart Conditions
 Heart Disease Q&A
 Heart Disease Symptoms
 Quiz: Your Heart Health IQ
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Medical Health Encyclopedia
 border=

Fibrin degradation products

Heart Disease Drugs Heart Disease Symptoms Heart Disease Treatment

How the test will feel:

When the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing.

Why the test is performed:

Text Continues Below



As a result of the coagulation process, fibrinogen is split into fibrin monomer and fibrin. Fibrin monomer forms the fibrin polymer clot.

Coagulation factor inhibitors and plasmin (which eventually breaks down, or lyses, the fibrin clot) are simultaneously activated by damaged tissue, but they function more slowly and over a longer period of time than the coagulation factors. The most important of the coagulation inhibitors is antithrombin III, a protein that requires a chemical called heparin, which is made by the body, for its activity.

By measuring FDPs, your doctor can get an idea about the activity of your fibrinolytic (clot-dissolving) system. When plasmin dissolves fibrin blood clots, FDPs are formed. These FDPs, which have an anticoagulant effect and inhibit clotting, can be measured. When they are present in large amounts, they indicate increased fibrinolysis, or clot breakdown, as occurs in disseminated intravascular coagulation (DIC) and primary fibrinolytic disorders.



A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Page:  << Prev | 1 | 2

 







About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy